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Marginal structural models were introduced in order to provide estimates of causal effects from
interventions based on observational studies in epidemiological research. The key point is that
this can be understood in terms of Girsanov’s change of measure. This offers a mathematical
interpretation of marginal structural models that has not been available before. We consider
both a model of an observational study and a model of a hypothetical randomized trial. These
models correspond to different martingale measures – the observational measure and the ran-
domized trial measure – on some underlying space. We describe situations where the randomized
trial measure is absolutely continuous with respect to the observational measure. The resulting
continuous-time likelihood ratio process with respect to these two probability measures corre-
sponds to the weights in discrete-time marginal structural models. In order to do inference for
the hypothetical randomized trial, we can simulate samples using observational data weighted
by this likelihood ratio.
Keywords: counting processes; marginal structural models; martingale measures; event history
analysis; Aalen’s additive hazard model
1. Introduction
We will consider the following scenario: A patient has a disease. In order to avoid an
event (e.g., death), a specific treatment can be given. The given treatment will typically
depend on the patient’s previous health condition.
We would like to estimate the effect of a given treatment on the time until the occur-
rence of the event. A natural way to do so is to implement some sort of randomized trial.
This means that we would have to set up an experiment on a group of patients where
the treatment was initiated by randomization independently of each patient’s previous
health condition. Such a study typically requires significant resources that may not be
available. In order to take advantage of another type of data, we could try to base our
estimates of the treatment effect on an observational study. Suppose we have observa-
tions of a group of patients where the given treatments were chosen by doctors. As a first
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attempt, one could try to compute the relative short-term risk between the group given
treatment and the group not given treatment at a particular time. This could be done
using Cox proportional hazards regression techniques. However, such a naive analysis
would most likely introduce a bias compared to the estimate based on the randomized
trial. The reason is that the health condition of the patient not already in treatment will
be a predictor of both treatment and death; that is, it is likely to be a confounder [19].
We can easily imagine two opposite scenarios where this confounder would complicate
estimates: Due to considerable costs, reduced life quality or possibly drug resistance, one
could decide that the treatment should not be initiated until the patients are sufficiently
ill. A naive marginal analysis based on data from an observational study would then
quickly lead us to believe that the treatment effect was less than the true treatment
effect. Conversely, if we decided only to initiate treatment for patients with good health
conditions and not for the ones with poor conditions, then a naive marginal analysis would
quickly lead us to believe that the treatment effect was better than the true treatment
effect.
In order to solve this problem, one might suggest that we compute an estimate of the
treatment effect conditionally on the health condition of the patient. However, in several
situations, it is likely that the previous treatment will improve the patient’s general
intermediate health condition. This improvement will in itself typically postpone the
time of death. The conditional effect estimate we described would only incorporate the
direct treatment effect, not the effect that is due to an improvement of the patient’s
intermediate health condition.
There is also another source of bias that we have to consider in order to lay hands on
the causal effect of treatment; that is, censoring. We assume that a patient may drop
out of the study at a time and not return; that is, we have right censoring. The given
treatment, calender time and the patient’s health condition might lead to such a drop
out. If we do a naive analysis based on the patients that are still in the study, then we
introduce a selection bias [9].
We are forced to move outside the standard Cox regression framework since we have to
deal with the mentioned time-dependent confounder effects due to a patient’s underlying
health condition. In order to provide a meaningful estimate of the treatment effect, with
a simple interpretation, we could try to construct a rich model that also describes the
dynamics of the underlying biological processes. Such mechanisms are likely to be very
complicated and there might not be sufficient knowledge or data available. For this reason
we could try to fit a marginal model of a suitable randomized trial for our scenario. This
will be our strategy in what follows.
One attempt to provide a marginal estimate of the causal treatment effect this way is
presented by Robins in [15]. This method uses marginal structural models and relies on
the additional assumption that there are no unmeasured confounders; that is, there does
not exist an unobserved process that is a predictor of both censoring and treatment, both
censoring and the event or both treatment and the event, given the observed covariates.
If every such process is measured, then the marginal structural model (MSM) approach
provides a proper adjustment of the marginal effect estimates. The idea is to apply some
clever weights to the observations. This weighting results in a pseudo-population that
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is different from the observed population. The key property of this pseudo-population
is that the selection bias and the treatment confounding due to the patient’s health
condition become negligible. Now, one can proceed with a weighted Cox regression to
obtain a marginal estimate of the effect of treatment. The method has been used several
times on epidemiological studies. In [8] it was used to estimate the effect of Zidovudine
on the survival of HIV-positive men in the Multicenter AIDS Cohort Study. Moreover,
the method was also used in [19] to give an estimate of the hazard ratio for the effect
of highly active antiviral treatment (HAART) on progression to AIDS or death for HIV
patients in Switzerland.
The method introduced by Robins deals with longitudinal data in discrete time. We
will consider continuous-time versions of the marginal structural models for event history
data. The idea is to characterize reasonable models of a randomized trial, the randomized
trial measures, using martingale theory. This offers a mathematical interpretation of
marginal structural models that has not been available before.
We characterize a class of of reasonable models of randomized trials in terms of lo-
cal independence. Such a model corresponds to a particular martingale measure. The
continuous-time likelihood ratio process between this measure and the observational
probability measure corresponds to the weights in a discrete-time marginal structural
model. In order to do inference for this new measure, we can simulate samples using the
observed data weighted by this likelihood ratio.
Another approach to causal inference within our scenario is to use the so-called struc-
tural nested models. These models were also introduced by Robins; see [16, 17]. Lok has
developed continuous-time versions of such models using counting processes and martin-
gale theory; see [13].
2. Observable processes and local independence
Before we come to the main results, we will spend some time establishing terminology.
Even if the mathematics involved is fairly standard stochastic process theory, it is perhaps
not so commonly used in event history analysis. A very good background reference on
stochastic processes that we will use frequently is [11].
2.1. Observable processes
In Section 3 we will consider a stochastic model of a single patient. There are typically
many factors that are important for describing how the disease of that individual devel-
ops in time. We will consider models where all the possible observations of one patient are
represented by stochastic integrals against Poisson processes. More formally, let d,n ∈N
and consider a probability space (Ω,F ,Q) with mutually orthogonal counting processes
N1t , . . . ,N
n
t on the interval [0, T ] and a filtration {Ft}t that is generated by their joint his-
tory and some initial information F0. The counting processes are assumed to be Poisson
processes in the sense that
N1t :=N
1
t − t, . . . ,N
n
t :=N
n
t − t
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define Q-martingales, the compensated Poisson processes. The probability measure Q
will only play a role as a reference measure, as we will mainly be interested in probabil-
ity measures that are absolutely continuous with respect to Q. This will sometimes be
referred to as the Poisson measure.
We let H be a bounded and Ft-predictable d×n-matrix-valued process and let X0 de-
note a bounded F0-measurable random vector. Now, define the d-dimensional observable
process :
Xt :=X0 +
∫ t
0
Hs dNs.
All the possible observations of a patient in our approach will be processes of this form.
Counting processes are trivially included in this class, but we also allow slightly more
complicated jump processes. One example could be measurements of blood values. Each
time the blood value is updated, it would be given by a jump and correspond to a jump
time of the underlying counting process. The size and direction of the jump would then
be given by the value of the predictable integrand H at the jump time.
2.2. Separability
We will say that two observable processes X and Y are separable if they allow the
representations:
Xt =X0 +
∫ t
0
HXs dN
X
s ,
Yt = Y0 +
∫ t
0
HYs dN
Y
s ,
whereNX andNY are independent components of the multivariate processN ,X0 and Y0
are bounded F0-measurable random vectors and H
X and HY are bounded matrix-valued
processes that are predictable with respect to the histories of NX and NY , respectively.
Separability is a technical assumption that provides well-behaved factorizations of likeli-
hoods. This is used in the proof of Theorem 1. Heuristically, it means that the processes
X and Y do reflect different random phenomena. Separability is even stronger than or-
thogonality since the processes are independent with respect to the Poisson measure Q.
However, since we will deal with other probability measures that are absolutely contin-
uous with respect to the Poisson measure, separable processes can not necessarily be
treated as independent.
2.3. A martingale measure
As we mentioned earlier, our samples will consist of paths of observable processes.
These samples will be distributed according to some probability measure P such that
a given family of predictable and non-negative processes define the jump intensities for
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N1, . . . ,Nn with respect to Ft. Since we assume that the observations are distributed
according to P , we will refer to such a measure as an observational measure.
More formally, we let λ1, . . . , λn be non-negative Ft-predictable processes and we as-
sume that P is a probability measure such that:
(1) P and Q coincide on F0,
(2) P ≪Q, i.e., P is absolutely continuous with respect to the Poisson measure,
(3) The equation
M it :=N
i
t −
∫ t
0
λis ds
defines a square-integrable P -martingale with respect to Ft for every i.
These properties characterize the probability measure P uniquely if such a measure exists,
[11], Theorem III 1.26.
2.4. Non-influence
We will need a notion of non-influence between observable processes. There are several
formal definitions that are meant to capture this; see [7]. Independence, or even condi-
tional independence, is too strong to be of interest for the method we have in mind. The
non-influence relation we will consider is local independence. Heuristically, a process X is
locally independent of a process Y if information about the past of Y does not contribute
to a better prediction of the short-term behavior of X .
In the setting of event history analysis, this concept has been studied thoroughly by
Didelez [6]. Schweder [18] used this concept in a study of composable Markov processes.
Aalen et al. made use of local independence in order to study the effect of menopause on
the risk of developing a certain skin disease in [3].
2.5. Local independence
Let X,Y,Z be observable processes that are mutually separable. The processes Xt−X0,
Yt−Y0 and Zt−Z0 are obviously independent with respect to the probability measure Q.
However, the situation is typically more complex with respect to the measure P , since
the jump intensities λ1t , . . . , λ
n
t could depend on all the information in Ft−. We therefore
introduce the following concept.
Definition 1. Let FX,Y,Zt denote the filtration generated by N
X ,NY ,NZ and let FX,Zt
denote the filtration generated by NX and NZ . We say that X is locally independent
of Y , given Z, if there exists an FX,Zt -predictable process µ such that
NXt −
∫ t
0
µs ds
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defines a local P -martingale with respect to FX,Y,Zt . If this is the case, then we write:
Y 9X |Z.
2.6. Independent censoring
Local independence generalizes a much-used concept in event history analysis, that is,
independent censoring. Suppose we can follow a group of individuals in a clinical trial.
We would like to compute the probability for an individual to survive longer than time t.
However, an individual might be censored at some time before the event due to the end of
the study or a “drop-out”. Inference is much simpler if the censoring does not influence
the instantaneous risk of the event. Therefore, it is common to assume independent
censoring. This means that an individual at risk has the same instantaneous risk of an
event as he would in the situation without censoring. More formally, this means that if
TD is the time of the event and TC is the time of censoring, then the compensator of
the process Dt := I(t ≥ TD) with respect to the joint event and censoring history only
depends on the event history. This is essentially the same as saying that D is locally
independent of the process defined by Ct := I(t≥ TC).
2.7. Local independence before a stopping time
Sometimes we may not be interested in dependencies that are considered trivial. This
could be dependencies due to an absorbing state (e.g., death). We will see that we can
rule out such trivial dependencies if we consider local independence before a stopping
time τ .
Definition 2. Let τ be an Ft-adapted stopping time. We say that X is locally inde-
pendent of Y before τ and given Z if there exists an {FX,Zt }t-predictable process µ such
that
NXt∧τ −
∫ t∧τ
0
µs ds
defines a local P -martingale with respect to {FX,Y,Zt }t. If this is the case, then we write:
Y 9τ X |Z.
If we let τ denote the time of the first jump of NY then it is not very hard to see,
using the explicit representation of FX,Y,Zt -predictable processes in [5], Theorem A.2,
that for every Ft-predictable process γ there exists an F
X,Z
t -predictable process γ˜ such
that γS · I(S ≤ τ) = γ˜S · I(S ≤ τ) P -a.s. for every Ft-adapted stopping time S. This
means that Y 9τ X |Z ; that is, stopping at the first jump of N
Y rules out every local
dependence of Y .
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2.8. Local independence graphs
Didelez also considered graphical models based on local independence; see [6]. These
graphs will prove to be very useful in order to represent complex models.
Definition 3. We say that a directed graph G= (E,V ) is a local independence graph if
the vertexes correspond to observable processes that are mutually separable and such that
(X,Y ) /∈E =⇒ X9τ Y |V \ {X,Y }.
Several examples of such graphs will appear below.
3. Models of clinical trials
3.1. A patient model
We will now describe a model of a single patient that participates in a clinical study. We
suppose that N is of the form (NA,NC ,ND,NL)′, where NA,NC ,ND are univariate
counting processes and NL is a multivariate counting process. These counting processes
count various events that are important for the development of the disease.
3.1.1. The event process
We let TD = inf{t > 0 |N
D
t = 1} and let
Dt :=
∫ t
0
I(s≤ TD) dN
D
s
be the event process. It jumps from 0 to 1 at the time the event occurs. The event could
be death or the progression to AIDS for an HIV patient.
3.1.2. Measurements of the underlying biological process
The state of an underlying biological process reflecting the patient’s health condition at
time t is given by
Lt := L0 +
∫ t
0
HLs dN
L
s ,
where L0 is a bounded F0-measurable random vector andH
L is a matrix-valued, bounded
and FLt -predictable process. The process L could be measurements of various blood
values.
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3.1.3. Right censoring
We assume that the patient can be right censored, that is, we will not be able to observe
the patient after some stopping time TC . This can happen because the study ends, but it
can also be a “drop-out” due to poor health or recovery. We assume that TC := inf{s >
0 |NCs 6= 0} and define the censoring process
Ct :=
∫ t
0
I(s≤ TC) dN
C
s .
3.1.4. The treatment process
One can switch between two treatments of the patient at the stopping time TA. This could
typically be to initiate treatment for a patient at risk. We let TA := inf{s > 0 |N
A
s 6= 0}
and define the treatment process
At :=
∫ t
0
I(s≤ TA) dN
A
s .
This means that the patient will not initially be in treatment. This somewhat limit-
ing assumption can be dropped, but then the considerations around the hypothetical
randomized trial at baseline will be much more involved.
3.2. Local independences with respect to the observational
measure
The process D influences the other processes. However, we consider these dependencies as
trivial. We will consider local independence before TD, because then we will automatically
have that D9TD A|C ∪L, D9TD C|A ∪L and D9TD L|A∪C.
We also assume that the censoring does not carry any information about the short
term behavior of the other process that we would not obtain if we left C out of the
analysis. In terms of local independence this means that C9TD A|D∪L, C9TD D|A∪L
and C 9TD L|A ∪D. We summarize these local independencies in the following local
independence graph:
(3.1)
3.3. Randomized trial measures
Our ultimate goal is to provide estimates of the causal effect of a particular treatment
based on observations of patients in an observational study.
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Hypothetically, one could carry out some randomized trial where the given treatment
did not depend on the previous health condition of the patient. If we had observations
from such a trial, we could easily provide simple estimators for the causal treatment effect
that would not require information about the underlying biological mechanisms. This is,
however, not the case for us. So, based on observations from the observational study, we
will try to simulate a counterfactual or hypothetical randomized trial. We assume that
we have measurements of all the relevant processes and variables. Especially, we assume
that the process L is complete in the sense that it gives rise to every event that affects
both the short-term behavior of the treatment and the event, both the censoring and
the event or both the censoring and the treatment, given the full covariate history. This
assumption means that all the confounder processes are measured and is usually referred
to as no unmeasured confounders.
In order to provide causal interpretation of simple estimators, we should at least require
the hypothetical trial to satisfy the following:
(1) Both the underlying biological process and the event process should dynamically
behave in the same way in the counterfactual trial and the observational study,
given the full covariate history.
(2) One should not allow drop-out due to poor health or recovery, that is, the censoring
should not be directly affected by the underlying health process, given the event
and treatment history.
(3) Since we consider time-dependent treatments, we have to generalize the notion
of a randomized trial slightly. In our counterfactual trial, the patient’s previous
health condition or censoring should not be relevant for the short-term behavior
of the treatment process. Heuristically, this means that the randomization should
act locally in time.
The counterfactual trial corresponds to a probability measure P˜ on the space (Ω,F).
We will refer to such a measure as a randomized trial measure. It carries the frequencies of
the potential observations in the counterfactual randomized trial. The above requirements
can now be translated into the following:
(1) The process M i is a local P˜ -martingale with respect to the filtration {Ft}t for
every i ∈D ∪L. This means that both the processes NL and ND have the same
intensity with respect to the randomized trial measure P˜ as with respect to the
observational measure P . Moreover, we assume that the observational measure
and the randomized trial measure coincide at baseline, that is,
EP [H ] =EP˜ [H ]
for every bounded F0-measurable random variable H .
(2) The censoring should be locally independent of the underlying health process L
with respect to P˜ , given the event and treatment history.
(3) The treatment process should be locally independent of the underlying health
process L and censoring C with respect to P˜ , given the event history.
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We summarize the local independence structure with respect to the randomized trial
measure P˜ in the following local independence graph:
A construction of reasonable randomized trials is given in Theorem 2. Before we come
to that, we will consider censoring in the counterfactual trial. In order to estimate the
total treatment effect, we will consider a marginal model where L is unobserved. One
natural choice of effect measure in the hypothetical experiment could be the hazard of
the event process with respect to the filtration {FA,Dt }t. In order to estimate the hazard
with respect to this filtration, we could try to estimate the hazard of the event before
censoring with respect to the filtration {FA,C,Dt }t. If, in addition, the event process was
locally independent of the censoring, given the treatment process, then these hazards
would coincide before censoring; that is, we would have independent censoring. This
would imply that the censoring would not cause bias in the sense that if we did not pay
attention to the underlying biological process, then the hazard of the event would not
depend on whether the patient had been censored or not. We will see in the next theorem
that this is the case for the randomized trial measures.
Theorem 1. If P is a randomized trial measure then we have C9TD A∪D, that is, we
have independent censoring in the marginalized model without L. This gives the following
local independence graph:
Proof. The likelihood ratio process
St :=
dP |Ft
dQ|Ft
is a Q-martingale with respect to Ft. This is shown in [11], Theorem III 3.4. The n-
dimensional Poisson process N has the martingale representation property with respect
to the filtration; see [11], Theorem III 4.37, so there exist predictable processes u1, . . . , un
such that:
St = 1+
n∑
i=1
∫ t
0
uis dN
i
s,
where N is :=N
i
s − s.
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Now, let
µis := I(Ss− > 0)
(
uis
Ss−
+ 1
)
and note that
1 +
n∑
i=1
∫ t
0
Ss−(µ
i
s − 1)dN
i
s = 1+
∫ t
0
I(Ss− > 0)dSs = St, Q-a.s. (3.2)
The last equality follows from [11], Lemma III 3.6.
Let M
(i)
t :=N
i
t −
∫ t
0
µis ds and note that since ∆N
i
s is bounded, [11], Lemma III 3.14,
says that the quadratic (co)variation process [N i, S] has locally integrable variation, so
its compensator 〈N i, S〉 is well defined. We can compute that
〈N i, S〉t =
∫ t
0
Ss−(µ
i
s − 1)d〈N
i,N i〉s =
∫ t
0
Ss−(µ
i
s − 1)ds,
so we get from Girsanov’s theorem (see [11], Lemma III 3.14) that
N
i
t −
∫ t
0
1
Ss−
d〈N i, S〉s =N
i
t −
∫ t
0
(µis − 1)ds=M
(i)
t
is a local P -martingale with respect to {Ft}t for every i≤ n.
Now
M
(i)
t −M
i
t =
∫ t
0
λs − µ
i
s ds
defines a continuous finite variation P -martingale, so µi = λi P -a.s. a.e. and S = E(K),
whereKt :=
∑n
i=1
∫ t
0
(λis−1)dN
i
s and E is the stochastic exponential. Let K
C
t :=
∫ t
0
(λCs −
1)dN
C
s and K
L
t :=K
C
t −Kt. Since [K
L,KC ] = 0 Q-a.s., we have that:
E(K) = E(KC +KL) = E(KC +KL + [KC ,KL]) = E(KC)E(KL). (3.3)
The last equality follows from [14], Theorem II 38.
We now consider filtrations corresponding to the σ-algebras: Gt := F
A,D
t∧TD
, GCt :=
FA,C,Dt∧TD , G
L
t :=F
A,D,L
t∧TD
and GC,Lt :=Ft∧TD . Moreover, we let λ˜
D denote the Gt-predictable
projection of λD; see [11], Theorem I 2.28. It is the unique Gt-predictable process such that
E[λDS |GS−] = λ˜
D
S
for every Gt-predictable stopping time S.
The local independence relations:
(1) L9TD C|A ∪C;
(2) C9TD L|A∪D;
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(3) C9TD A|L∪D;
(4) C9TD D|A ∪L
and (3.3) provide a factorization
dP |
G
C,L
t−
dQ|
G
C,L
t−
= SLt · S
C
t ,
where SL is GLt -predictable and S
C is GCt -predictable. Bayes’ theorem now gives that,
whenever F is GLt−-measurable and bounded, then
E[F |Gt−] =E[F |G
C
t−] (3.4)
P -a.s. Therefore, if we let F be bounded and GCt -predictable, then we can compute:
E
[∫ T
0
Fsλ˜
D
s ds
]
=
∫ T
0
E[Fsλ˜
D
s ] ds=
∫ T
0
E[FsE[λ
D
s |Gs−]] ds
=
∫ T
0
E[FsE[λ
D
s |G
C
s−]] ds=
∫ T
0
E[E[Fsλ
D
s |G
C
s−]] ds
= E
[∫ T
0
Fsλ
D
s ds
]
.
If we let M˜Dt =Dt −
∫ t
0
λ˜Ds ds and M
D
t =Dt −
∫ t
0
λDs ds, then we can compute:
E
[∫ T
0
Fs dM˜
D
s
]
= E
[∫ T
0
Fs dDs
]
−E
[∫ T
0
Fsλ˜
D
S ds
]
= E
[∫ T
0
Fs dDs
]
−E
[∫ T
0
Fsλ
D
S ds
]
= E
[∫ T
0
Fs dM
D
s
]
= 0,
so M˜D is a P -martingale with respect to the filtration GCt . Now, since Gt ⊂ G
L
t , we have
that λ˜D is GLt -predictable:
M˜Dt = E[M˜
D
TD
|GCt ] =E[M˜
D
TD
I(T < t) + M˜DTDI(T ≥ t)|G
C
t ]
= M˜DTDI(T < t) +E[M˜
D
TD
I(T ≥ t)|GCt ]
= M˜DTDI(T < t) +E[M˜
D
TD
|FA,C,Dt ]I(T ≥ t)
= E[M˜DTD |F
A,C,D
t ],
that is, M˜D is a P -martingale with respect to the filtration {FA,C,Dt }t.
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Finally, we note that
NAt∧TD −
∫ t
0
λAs I(s≤ TD) ds (3.5)
defines a P -martingale with respect to Ft. Since λ
A
s is F
A,D
t -predictable, we also see
that (3.5) defines a martingale with respect to {FA,C,Dt }t. 
4. Existence of randomized trial measures
We have now come to the construction of randomized trial measures. The idea is to
construct a reasonable randomized trial measure P˜ from the observational measure P
such that P˜ ≪ P . The absolute continuity is important since this provides a natural
method for simulating the empirical expectation of random variables as if the data was
sampled from the counterfactual trial, while actually using P -distributed samples. To
get an idea of how this is done, let J ∈ N, let H be a bounded random variable and let
ω1, . . . , ωJ be J independently P -distributed samples from Ω. The law of large numbers
then yields:
lim
J→∞
1
J
J∑
j=1
dP˜
dP
(ωj)H(ωj) =EP
[
dP˜
dP
H
]
=EP˜ [H ], P -a.s.
Heuristically, this means that the likelihood ratio can be viewed as a transformation from
the observational study into the counterfactual scenario.
There might exist several reasonable counterfactual trials, each corresponding to
a choice of a well-behaved treatment and censoring strategies. Given a non-negative
FA,Dt -predictable process λ˜
A and a non-negative FA,C,Dt -predictable process λ˜
C , we can
consider the problem of finding a randomized trial measure P˜ that has λ˜A as the Ft-
intensity of NA and λ˜C as the Ft-intensity of N
C . This suggests that λ˜A is the treatment
strategy and λ˜C is the censoring strategy in the counterfactual trial. We will consider
the counterfactual treatment strategy given by the P -intensity of NA with respect to
FA,Dt . The counterfactual censoring strategy will be given by the P -intensity of N
C with
respect to FA,D,Ct . This gives a randomized trial measure with a likelihood ratio that
heuristically corresponds to the stabilized weights one usually considers in the discrete
time marginal structural models; see [15]. The problem of finding such a randomized
trial measure is a martingale problem. Note that this problem might not have a solu-
tion. The next theorem shows that if the counterfactual strategies are not too different
from the observed intensities, then there exists a unique corresponding randomized trial
measure P˜ .
Theorem 2. Suppose that there exist positive numbers θ1 and θ2 such that:
λAs − θ1
√
λAs ≤EP [λ
A
s |F
A,D
s− ]≤ λ
A
s + θ1
√
λAs (4.1)
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and
λCs − θ2
√
λCs ≤EP [λ
C
s |F
A,C,D
s− ]≤ λ
C
s + θ2
√
λCs (4.2)
for almost every s P -a.s. Let λ˜A denote the P -intensity of NA with respect to the filtration
{FA,Dt }t and let λ˜
C denote the P -intensity of NC with respect to the filtration {FA,C,Dt }t.
The equation
Rt :=
∏
s≤t
(
λ˜As
λAs
)∆NAs
exp
(∫ t
0
λ˜As − λ
A
s ds
)
(4.3)
×
∏
s≤t
(
λ˜Cs
λCs
)∆NCs
exp
(∫ t
0
λ˜Cs − λ
C
s ds
)
defines a square-integrable P -martingale with respect to the filtration {Ft}t. Moreover,
dP˜ =RT dP
defines a randomized trial measure on (Ω,F) such that the martingale dynamics of the
biological processes D and L coincide for the two probability measures P˜ and P , that is,
Lt −
∫ t
0
HLs λ
L
s ds and Dt −
∫ t
0
λDs I(s≤ TD) ds
also define P˜ -martingales with respect to {Ft}t.
Proof. We define
Kt :=
∫ t
0
((
λ˜As
λAs
− 1
)
dMAs +
∫ t
0
(
λ˜Cs
λCs
− 1
))
dMCs .
By the innovation theorem, we have that
λ˜As =EP [λ
A
s |F
A,D
s− ] and λ˜
C
s =EP [λ
C
s |F
A,C,D
s− ] P -a.s., s-a.e. (4.4)
By (4.1) and (4.2) we have that
(
λ˜As
λAs
− 1
)2
λAs +
(
λ˜Cs
λCs
− 1
)2
λCs ≤ θ1 + θ2, P -a.s., s-a.e.
We therefore obtain that:
〈K,K〉t =
∫ t
0
((
λ˜As
λAs
− 1
)2
λAs +
(
λ˜Cs
λCs
− 1
)2
λCs
)
ds≤ (θ1 + θ2) · t.
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Since 〈K,K〉 is bounded on the interval [0, T ], [12], Theorem II.1, yields that the
stochastic exponential R := E(K), given by the SDE:
Rt = 1+
∫ t
0
Rs− dKs (4.5)
is square-integrable.
Now
d˜P =RT dP
defines a probability measure P˜ on (Ω,F).
Note that we have:
MD −
∫ ·
0
1
Rs−
d〈MD,R〉s =M
D and M l −
∫ ·
0
1
Rs−
d〈M l,R〉s =M
l
P -a.s. for every l ∈ L. Moreover, Girsanov’s theorem (see [11], Lemma III 3.14) gives
that these processes define local P˜ -martingales with respect to the filtration {Ft}t.
Moreover,
〈MA,R〉t =
∫ t
0
Rs−
(
λ˜As
λAs
− 1
)
d〈MA,MA〉s =
∫ t
0
Rs−(λ˜
A
s − λ
A
s ) ds,
so again by Girsanov’s theorem, we have that
MAt −
∫ t
0
1
Rs−
d〈MA,R〉s =M
A
t −
∫ t
0
λ˜As − λ
A
s ds=N
A
t −
∫ 1
0
λ˜As ds
defines a P˜ -martingale with respect to the filtration {Ft}t. Analogously, we have that
MDt −
∫ t
0
1
Rs−
d〈MD,R〉s =N
D
t −
∫ t
0
λ˜Ds ds
defines a local P˜ -martingale with respect to the filtration {Ft}t.
Finally, we note that by [11], Theorem I 4.60, the SDE (4.5) has the explicit solution
given by (4.3). Expressions of this form are well known in the literature on marked point
process; see, for instance, [10]. 
Remark 1. Note that the condition (4.1) heuristically means that the short-term “risk”
of starting treatment, given the previous full history,
lim
h→0
h−1P (t≤ TA < t+ h|Ft),
is not too different from the short-term “risk” of starting treatment when we do not pay
attention to the underlying health process or censoring, that is,
lim
h→0
h−1P (t≤ TA < t+ h|F
A,D
t ).
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Similarly, condition (4.2) heuristically means that the short-term “risk” of being cen-
sored, given the previous full history, is not too different from the short-term “risk” of
being censored when we do not pay attention to the underlying health process. In words,
this means that the previous history of the health process L alone can not at any time
yield too high of a short-term “risk” of starting treatment or being censored.
5. Weighted additive hazard regression
Suppose that we have observations of m independent individuals until death or censoring
from an observational study and want to estimate the total effect of treatment. Ideally,
we would like to base our estimate on some randomized trial. However, such a trial
might not be available. The marginal structural approach now suggests that we simulate
a counterfactual randomized trial, using the data we already have. We would then like
to estimate the counterfactual hazard, that is, the hazard that the patient would have if
he, contrary to the fact, had participated in the randomized trial. In this way we could
compare the total effect of being in treatment versus never being in treatment.
We assume that the observations from each individual are P -distributed. The observa-
tions of the patient would have been P˜ -distributed if he, contrary to the fact, participated
in the hypothetical randomized trial.
We assume that the counterfactual intensity follows Allen’s additive hazard regression
model, see [1, 2]. To formalize this, let β0 and β1 be functions on [0, T ]. We assume that
we only have instantaneous effect and that the hazard for the event, with respect to the
treatment and event history, is given by:
β0t + β
1
tAt−.
One way to estimate the hazard from the counterfactual trial is to weight the obser-
vations by the corresponding likelihood ratios. We will prove that a suitable weighted
variant of Aalen’s additive hazard regression gives consistent estimators of
∫ t
0
β0s ds and∫ t
0
β1s ds from independent P -distributed observations. This requires some notation. Let
Y 1s , . . . , Y
m
s be the “at-risk” indicators and A
1
t , . . . ,A
m
t be the “at-treatment” indicators
for the m independent individuals. We define the m× 2-matrix:
X
(m)
t =


Y 1t Y
1
t ·A
1
t−
...
...
Y mt Y
m
t ·A
m
t−

 .
Moreover, let R1t , . . . ,R
m
t be the individual likelihood ratios at time t and let
R
(m)
t− =


Y 1t R
1
t− 0 . . . 0
0 Y 2t R
2
t−
...
...
. . . 0
0 0 . . . Y mt R
m
t−

 .
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Finally, let D1t , . . . ,D
m
t be event processes for the m individuals before t. The observed
events are now given by the vector
D
(m)
t =


∫ t
0
Y 1s dD
1
s
...∫ t
0
Y ms dD
m
s

 .
Theorem 3. We assume that:
(1) The P -intensity of D with respect to the filtration Ft, λ
D is dominated by an
integrable function G.
(2) (Positivity) Both the “at-risk” groups in the counterfactual trial are always present,
that is,
EP˜ [YsAs−]> 0 and EP˜ [Ys(1−As−)]> 0
for every s ∈ [0, T ].
(3) There exist integrable and left-continuous functions with right limits β0 and β1
such that β = (β0, β1)T and such that
D
(m)
t −
∫ t
0
X(m)s βs ds
is a P˜ -martingale with respect to the filtration FA,C,Dt , i.e., Yt(β
0
t + β
1
tA
1
t−) is the
P˜ -intensity of D w.r.t. the filtration FA,C,Dt .
We let
J (m)s := I
(
m∑
i=1
Rit−Y
i
t (1−A
i
t−)> 0 and
m∑
i=1
Rit−Y
i
t A
i
t− > 0
)
,
Bˆ
(m)
t :=
∫ t
0
J (m)s (X
(m)T
s R
(m)
s− X
(m)
s )
−1
X(m)Ts R
(m)
s− dD
(m)
s
and
Bt :=
∫ t
0
βs ds.
Now Bˆ(m) is a consistent estimator of Bt in the sense that:
lim
m
P (d(Bˆ(m),B)≥ ǫ) = 0
for every ǫ > 0, where d denotes the Skorokhod metric; see [11] or [4].
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Proof. We define:
Y
(m)
t =


Y 1t
...
Y mt

 , λ(m)t =


λ1t
...
λmt

 and M (m)t =


D1t −
∫ t
0
λ1s ds
...
Dmt −
∫ t
0
λms ds

 .
We will often drop the index (m) in order to simplify the notation. Another simplification
of the notation we will use is E[·] for the expectation with respect to P and E˜[·] for the
expectation with respect to P˜ .
First we prove that
lim
m
P
(
sup
t≤T
∣∣∣∣
∫ t
0
Js(X
T
s Rs−Xs)
−1XTs Rs−λs ds−Bt
∣∣∣∣≥ ǫ
)
= 0 (5.1)
for every ǫ > 0. Define:
V :=
(
1 0
−1 1
)
and St :=


m∑
i=1
Rit−Y
i
t (1−A
i
t−) 0
0
m∑
i=1
Rit−Y
i
t A
i
t

 .
The matrix V is invertible and, using the fact that the Y i and the Ai are indicators, we
have:
V TXTt Rt−XtV = St,
that is, XTt Rt−Xt is congruent to the diagonal matrix St. A simple matrix computation
gives that
(XTt Rt−Xt)
−1 = V S−1t V
T,
when Js > 0.
Now, we see that:
Jt(X
T
t Rt−Xt)
−1XTt Rt−λt = JtV (H )
0
t H
1
t ,
where
H0t =
∑m
i=1R
i
t−Y
i
t (1−A
i
t−)λ
i
t∑m
i=1R
i
t−Y
i
t (1−A
i
t−)
and H1t =
∑m
i=1R
i
t−Y
i
t A
i
t−λ
i
t∑m
i=1R
i
t−Y
i
t A
i
t−
.
Since E˜[YtAt−]> 0, the law of large numbers implies that H
0
t converges in probability
to
E˜[Yt(1−At−)λ
D
t ]
E˜[Yt(1−At−)]
= E˜[λDt |Yt(1−At−) = 1].
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Analogously, since E[Yt(1−At−)]> 0, we have that H
1
t converges in probability to
E˜[YtAt−λ
D
t ]
E˜[YtAt−]
= E˜[λDt |YtAt−1 = 1].
By a similar argument, we see that {J
(m)
s } converges in probability to 1 for almost
every s.
Since the P -intensity of D with respect to FA,C,Ds coincides with E[λ
D
s |F
A,C,D
s− ] P -a.s.
for almost every s, we have that:
E˜[λD|Yt(1−At−) = 1] = β
0
t and E˜[λ
D
t |YtAt− = 1] = β
0
t + β
1
t .
This means that
Js(X
T
t Rt−Xt)
−1XTt Rt−λt (5.2)
converges in probability to βt when m increases. Note that
E
[
sup
t
∣∣∣∣
∫ t
0
JsV
(
H0s
H1s
)
ds−
∫ t
0
βs ds
∣∣∣∣
]
≤
∫ T
0
E
[∣∣∣∣JsV
(
H0s
H1s
)
− βs
∣∣∣∣
]
ds,
so by the dominated convergence theorem, we obtain (5.1).
We will now prove that
Zt := Bˆt −
∫ t
0
Js(X
T
s Rs−Xs)
−1XTs Rs−λs ds
=
∫ t
0
(XTs Rs−Xs)
−1XTs Rs− dMs
converges weakly to 0. Note that:
〈Z,Z〉t =
∫ t
0
Js(X
T
s Rs−Xs)
−1XTs Rs− d〈M,M〉sRs−Xs(X
T
s Rs−Xs)
−1
=
∫ t
0
JsV S
−1
s V
TXTs Rs− d〈M,M〉sRs−XsV S
−1
s V
T
= V
∫ t
0
JsS
−2
s Us dsV
T,
where
Us =


m∑
i=1
Ri2s−Y
i
s (1−A
i
s−)λ
i
s 0
0
n∑
i=1
Ri2s−Y
i
sA
i
s−λ
i
s

 .
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Now,
E
[
sup
t
∣∣∣∣
∫ t
0
V JsS
−2
s UsV
T ds
∣∣∣∣
]
≤
∫ T
0
E[|V JsS
−2
s UsV
T|] ds,
so, by the dominated convergence theorem, {〈Z(m), Z(m)〉} converges uniformly in prob-
ability to 0.
We define
Z
(ǫ,m)
t :=
∫ t
0
I(|Js(X
T
s Rs−Xs)
−1XTRs−Ys| ≥ ǫ)Js(X
T
s Rs−Xs)
−1XTRs− dMs
and see that
0≤ 〈Z(ǫ,m), Z(ǫ,m)〉t ≤ 〈Z
(m), Z(m)〉t.
Since both
{〈Z(ǫ,m), Z(ǫ,m)〉}m and {〈Z
(m), Z(m)〉}m
converge uniformly in probability to 0, the central limit theorem for martingales ([11],
Theorem VIII 3.22) implies that {Z(m)}m converges weakly to 0.
We have that
Bˆ
(m)
t = Z
(m)
t +
∫ t
0
Js(X
T
s Rs−Xs)
−1XTs Rs−λ
(m)
s ds,
so the sequence {Bˆ(m)}m is the sum of two C-tight sequences. Jacod and Shiryaev [11],
Corollary VI 3.33, implies that the sequence itself is also C-tight. By Slutsky’s theorem,
the finite-dimensional distributions on the form L(Bˆ
(m)
t1
, . . . , Bˆ
(m)
tj
) converge weakly to
the Dirac measures: δBt1 ,...,Btj . This means that {Bˆ
(m)}m converges in law and therefore
in probability to B. 
6. Concluding remarks
We have shown that marginal structural modeling can be understood in terms of change
of probability measures. The author believes that this is an elucidating point of view
that is natural in the framework of modern probability theory.
As stressed by several authors, there is a very important and highly non-trivial as-
sumption one has to make in order to interpret effects from marginal structural models
as causal. This is the assumption of no unmeasured confounders, or equivalently: all
confounders are measured. This means that every process that affects the short-term
behavior of both the treatment and the censoring or both the treatment and the event
must be observed. In this equivalent form, it becomes more apparent that this is just
an assumption about completeness of the model. This completeness assumption is not
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that mysterious. When modeling various phenomena in the natural sciences, one typi-
cally assumes that all the important variables are contained in the model. This is also
necessary in the MSM approach. However, it is important to note that this is not gener-
ally a statistically testable assumption. It is also not a condition that would follow from
a mathematical argument without further assumptions about the model.
Heuristically, the MSM approach provides an adjustment of the the treatment effect
bias caused by the measured confounders. In the marginal structural model approach,
instead of modeling the underlying and potentially very complicated biology, one models
a randomized trial. The problem of computing marginal effects then splits into two parts.
The first problem is to model the marginal intensity of the event in the simulated “ran-
domized trial”. If one knew the corresponding likelihood ratio process, then this would be
obtainable using, for instance, the weighted additive hazard regression from the previous
section. In order to compute this likelihood ratio, one has to deal with the second part
of our problem. That is to model the dynamics of the treatment and censoring processes
given the full and the marginal history in the observational study. This is a crucial point.
We have chosen not to deal with this problem in the current paper. However, one could
use regression techniques to do this at least approximately. In the discrete time setting,
one typically uses pooled logistic regressions see [8, 19]. In the continuous-time setting
it is probably more natural to use additive hazard or Poisson regression to estimate the
censoring and treatment intensities, both with respect to the full covariate history and
marginal covariate history. This will be the topic of future work. Once these intensities
are known, one can compute the likelihood ratio process using (4.3).
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